Document ID: chunk:federal_register_of_legislation:F2024L01277:reg:4
Version: federal_register_of_legislation:F2024L01277
Segment Type: reg
Provision Reference: reg 4
Character Range: 1605–3004

4  Definitions
 (1) In this instrument:
Act means the National Health Act 1953.
increased maximum quantity of a pharmaceutical benefit means the maximum quantity or number of units of the benefit or the pharmaceutical item in the benefit that may, in one prescription, be directed to be supplied on any one occasion, for a relevant purpose, under a determination of the Minister under paragraph 85A(2)(a) of the Act.
increased maximum quantity prescription means a prescription directing, for a relevant purpose, the supply on any one occasion of the increased maximum quantity of a pharmaceutical benefit.
relevant purpose, for a pharmaceutical benefit, means a purpose, mentioned in Schedule 4 to the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 for a purposes code (within the meaning of that instrument) specified in Schedule 1 to that instrument for the benefit, that includes the phrase "The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient".
 (2) An expression that is used in this instrument and in Part VII of the Act has the same meaning in this instrument as it has in that Part.
Note: Examples of such expressions include the following:
(a) ACSS eligible supply;
(b) ACSS payment;
(c) approved pharmacist;
(d) pharmaceutical benefit;
(e) pharmaceutical item;
(f) Schedule equivalent.